Moderna and Carisma collaborate to develop in-vivo engineered CAR-M for oncology
The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M)…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.